{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:24:27Z","timestamp":1786940667523,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06251-9","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:20:14Z","timestamp":1784690414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis E virus infection: considerations for immunologists and rheumatologists"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6153-321X","authenticated-orcid":false,"given":"Piotr","family":"Kacprzyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3952-1145","authenticated-orcid":false,"given":"Pawe\u0142","family":"Piluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3214-6990","authenticated-orcid":false,"given":"Piotr","family":"G\u0142owacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-0302","authenticated-orcid":false,"given":"Maria","family":"Ma\u015bli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"5","key":"6251_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","volume":"84","author":"L Guillevin","year":"2005","unstructured":"Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P (2005) Hepatitis B Virus-Associated Polyarteritis Nodosa. Med (Wolters Kluwer) 84(5):313\u2013322. https:\/\/doi.org\/10.1097\/01.md.0000180792.80212.5e","journal-title":"Med (Wolters Kluwer)"},{"issue":"1","key":"6251_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","volume":"79","author":"P Cacoub","year":"2000","unstructured":"Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto A-M, Camproux A-C, Hausfater P, Musset L, Veyssier P, Raguin G, Piette J-C, Germmc ft (2000) Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients. Med (Wolters Kluwer) 79(1):47\u201356. https:\/\/doi.org\/10.1097\/00005792-200001000-00005","journal-title":"Med (Wolters Kluwer)"},{"issue":"3","key":"6251_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00296-022-05169-2","volume":"43","author":"E Capkin","year":"2022","unstructured":"Capkin E, Yaz\u0131c\u0131 A, Karkucak M, Durmaz Y, Toprak M, Ataman \u015e, \u015eahin N, C\u00fczdan N, Kasapo\u011fluAksoy M, \u00d6nder ME, SerdarogluBeyazal M, Mesci N, Baykul M, AlkanMeliko\u011flu M, Alkan H, Dulgeroglu D, Cengiz AK, Nas K, BaleviBatur E, \u00c7al\u0131\u015fkanU\u00e7kun A, Deveci H, Erol K, AlbayrakGezer \u0130, Akg\u00f6l G, Duru\u00f6z MT, K\u00fc\u00e7\u00fckakka\u015f O, Sar\u0131kaya S, Rezvani A, Atan T, G\u00f6\u011f\u00fc\u015f F, \u00c7a\u011flayan G, Keskin Y, BulutKeskin AS, \u00d6z N, Y\u0131lmaz G (2022) Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study. Rheumatol Int 43(3):523\u2013531. https:\/\/doi.org\/10.1007\/s00296-022-05169-2","journal-title":"Rheumatol Int"},{"key":"6251_CR4","doi-asserted-by":"publisher","unstructured":"Songtanin B, Molehin AJ, Brittan K, Manatsathit W, Nugent K (2023) Hepatitis E virus infections: epidemiology, genetic diversity, and clinical considerations. Viruses 15(6). https:\/\/doi.org\/10.3390\/v15061389","DOI":"10.3390\/v15061389"},{"key":"6251_CR5","doi-asserted-by":"publisher","unstructured":"Alfonsi A, Roman\u01d2 L, Ciccaglione AR, La Rosa G, Bruni R, Zanetti A, Della Libera SD, Iaconelli M, Bagnarelli P, Capobianchi MR, Garbuglia AR, Riccardo F, Tosti ME, Ferrigno L, Crateri S, Galli C, Tagliacarne C, Giordani MT, Morelli E, Vit A, Bertin T, Marinello S, de Checchi G, Zotti C, Amprino V, Rossati A, Di Vito A, Guidoni C, Fiacchini D, Marinelli K, Loffredo M, de Angelis G, Citarella A, Megnia AS (2018) Hepatitis e in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016. Eurosurveillance 23(41). https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.41.1700517","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700517"},{"issue":"11","key":"6251_CR6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"issue":"S1","key":"6251_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/liv.14880","volume":"41","author":"H Larrue","year":"2021","unstructured":"Larrue H, Abravanel F, P\u00e9ron JM (2021) Hepatitis E, what is the real issue? Liver Int 41(S1):68\u201372. https:\/\/doi.org\/10.1111\/liv.14880","journal-title":"Liver Int"},{"issue":"1","key":"6251_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12985-024-02470-3","volume":"21","author":"A Letafati","year":"2024","unstructured":"Letafati A, Taghiabadi Z, Roushanzamir M, Memarpour B, Seyedi S, Farahani AV, Norouzi M, Karamian S, Zebardast A, Mehrabinia M, Ardekani OS, Fallah T, Khazry F, Daneshvar SF, Norouzi M (2024) From discovery to treatment: tracing the path of hepatitis E virus. Virol J 21(1):194. https:\/\/doi.org\/10.1186\/s12985-024-02470-3","journal-title":"Virol J"},{"issue":"2","key":"6251_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2015.10.048","volume":"150","author":"G-H Lee","year":"2016","unstructured":"Lee G-H, Tan B-H, Chi-YuanTeo E, Lim S-G, Dan Y-Y, Wee A, KimAw PP, Zhu Y, Hibberd ML, Tan C-K, Purdy MA, Teo C-G (2016) Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology 150(2):355\u2013357e353. https:\/\/doi.org\/10.1053\/j.gastro.2015.10.048","journal-title":"Gastroenterology"},{"key":"6251_CR10","doi-asserted-by":"publisher","unstructured":"Wolski A, Pischke S, Ozga AK, Addo MM, Horvatits T (2023) Higher risk of HEV transmission and exposure among blood donors in Europe and Asia in comparison to North America: a meta-analysis. Pathogens 12(3). https:\/\/doi.org\/10.3390\/pathogens12030425","DOI":"10.3390\/pathogens12030425"},{"issue":"5","key":"6251_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.20524\/aog.2022.0731","volume":"35","author":"K Zachou","year":"2022","unstructured":"Zachou K, Azariadis K, Sofia M, Lyberopoulou A, Arvaniti P, Gatselis N, Spyrou V, Billinis C, Dalekos GN (2022) Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars. Annals Gastroenterol 35(5):532\u2013540. https:\/\/doi.org\/10.20524\/aog.2022.0731","journal-title":"Annals Gastroenterol"},{"issue":"2","key":"6251_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/pathogens15020205","volume":"15","author":"MM Williman","year":"2026","unstructured":"Williman MM, Colina SE, DiCola G, Ozaeta DS, Carpinetti BN, Pisano MB, R\u00e9 VE, Serena MS, Echeverr\u00eda MG, Metz GE (2026) Evidence of wild boars as a reservoir of zoonotic hepatitis E virus genotype 3: implications for Public Health in Argentina. Pathogens 15(2):205. https:\/\/doi.org\/10.3390\/pathogens15020205","journal-title":"Pathogens"},{"issue":"2","key":"6251_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/iid3.411","volume":"9","author":"P Affeldt","year":"2021","unstructured":"Affeldt P, Di Cristanziano V, Grundmann F, Wirtz M, Kaiser R, Benzing T, Stippel D, Kann M, Kurschat C (2021) Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation. Immun Inflamm Dis 9(2):513\u2013520. https:\/\/doi.org\/10.1002\/iid3.411","journal-title":"Immun Inflamm Dis"},{"key":"6251_CR14","doi-asserted-by":"publisher","unstructured":"Boone I, Janssen S, Marcotty T, Moos V, Allers K, Geelhaar-Karsch A, Schneider T, Al Dahouk S (2025) Risk factors for foodborne zoonoses among populations with and without a migration background in Berlin, Germany. Trop Med Infect Disease 10(10). https:\/\/doi.org\/10.3390\/tropicalmed10100281","DOI":"10.3390\/tropicalmed10100281"},{"key":"6251_CR15","doi-asserted-by":"publisher","unstructured":"Ceccarelli F, Dorrucci M, Pirone C, Mataj E, Garufi C, Farchi F, Bruni R, Villano U, Madonna E, Iaiani G, Ciccozzi M, Ciccaglione AR, Conti F, Lo Presti A (2024) Hepatitis E virus infection in patients with systemic and cutaneous lupus erythematosus. Int J Mol Sci 25(20). https:\/\/doi.org\/10.3390\/ijms252011162","DOI":"10.3390\/ijms252011162"},{"issue":"5","key":"6251_CR16","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1016\/S2352-3026(25)00049-3","volume":"12","author":"M Mikulska","year":"2025","unstructured":"Mikulska M, van Boemmel F, Mouliade C, Indolfi G, Kefalakes H, von Lilienfeld-Toal M, Pischke S, Hermine O, Moradpour D, Wedemeyer H, Berg T, Ljungman P, Mallet V (2025) Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9). Lancet Haematol 12(5):e389\u2013e399. https:\/\/doi.org\/10.1016\/S2352-3026(25)00049-3","journal-title":"Lancet Haematol"},{"issue":"3","key":"6251_CR17","doi-asserted-by":"publisher","first-page":"e0013980","DOI":"10.1371\/journal.pntd.0013980","volume":"20","author":"MK Ahmed","year":"2026","unstructured":"Ahmed MK, Maroofi H, Blunt M, Labrique A, Kirkwood C, Vannice K, Talaat KR, Lynch J, Kmush BL (2026) Current global estimates, risk factors, and knowledge gaps for Hepatitis E virus (HEV): a scoping review. PLoS Negl Trop Dis 20(3):e0013980. https:\/\/doi.org\/10.1371\/journal.pntd.0013980","journal-title":"PLoS Negl Trop Dis"},{"key":"6251_CR18","doi-asserted-by":"publisher","unstructured":"Lampejo T, Curtis C, Ijaz S, Haywood B, Flores A, Sudhanva M, El-Bouzidi KE, Patel S, Dowling M, Zuckerman M (2022) Nosocomial transmission of hepatitis E virus and development of chronic infection: the wider impact of COVID-19. J Clin Virol 148. https:\/\/doi.org\/10.1016\/j.jcv.2022.105083","DOI":"10.1016\/j.jcv.2022.105083"},{"issue":"8","key":"6251_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hepr.14062","volume":"54","author":"T Kanda","year":"2024","unstructured":"Kanda T, Li TC, Takahashi M, Nagashima S, Primadharsini PP, Kunita S, Sasaki-Tanaka R, Inoue J, Tsuchiya A, Nakamoto S, Abe R, Fujiwara K, Yokosuka O, Suzuki R, Ishii K, Yotsuyanagi H, Okamoto H, Totsuka M, Honda M, Arima S, Masuzaki R, Matsumoto N, Ogawa M, Abe H, Nakamura M, Wu S, Kato N, Yokoo T, Hayashi K, Kamimura H, Terai S, Kang JH, Kobayashi T, Isoda N, Watanabe S, Mizuo H, Koyama J, Takagi H, Yamazaki Y, Sato Y, Okano H, Nakano T, Kawakami M, Miyasaka A, Koibuchi T, Sugiyama R, Matsuda M, Hirai-Yuki A (2024) Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatol Res 54(8):1\u201330. https:\/\/doi.org\/10.1111\/hepr.14062","journal-title":"Hepatol Res"},{"issue":"3","key":"6251_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/liv.14695","volume":"41","author":"G Buescher","year":"2021","unstructured":"Buescher G, Ozga AK, Lorenz E, Pischke S, May J, Addo MM, Horvatits T (2021) Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis. Liver Int 41(3):449\u2013455. https:\/\/doi.org\/10.1111\/liv.14695","journal-title":"Liver Int"},{"issue":"3","key":"6251_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/livers3030035","volume":"3","author":"S Urooj","year":"2023","unstructured":"Urooj S, Anjum S, Iqbal F, Abduh MS, Akhtar H, Javed S, Kakar SJ, Ikram A, Maqbool NA, Ahmad T (2023) Hepatitis E virus: epidemiology, clinical aspects, and its significance as a major pregnancy risk. Livers 3(3):507\u2013528. https:\/\/doi.org\/10.3390\/livers3030035","journal-title":"Livers"},{"key":"6251_CR22","doi-asserted-by":"publisher","unstructured":"Binda B, Picchi G, Bruni R, Di Gasbarro A, Madonna E, Villano U, Pisani G, Carocci A, Marcantonio C, Montali F, Panarese A, Pisani F, Ciccaglione AR, Spada E (2025) The prevalence, risk factors, and outcomes of hepatitis E virus infection in solid organ transplant recipients in a highly endemic area of Italy. Viruses 17(4). https:\/\/doi.org\/10.3390\/v17040502","DOI":"10.3390\/v17040502"},{"issue":"9","key":"6251_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.5152\/tjg.2021.20870","volume":"32","author":"O Sezgin","year":"2021","unstructured":"Sezgin O, Yara\u015f S, Ulger ST, Aslan G, Tiftik EN (2021) The prevalence of hepatitis e virus infection in the adult turkish population: a systematic review of the literature and prevalence study in blood donors in mersin province. Turkish J Gastroenterol 32(9):782\u2013789. https:\/\/doi.org\/10.5152\/tjg.2021.20870","journal-title":"Turkish J Gastroenterol"},{"key":"6251_CR24","doi-asserted-by":"publisher","unstructured":"Aggarwal R, Goel A (2019) Natural history, clinical manifestations, and pathogenesis of hepatitis e virus genotype 1 and 2 infections. Cold Spring Harbor Perspect Med 9(7). https:\/\/doi.org\/10.1101\/cshperspect.a032136","DOI":"10.1101\/cshperspect.a032136"},{"issue":"4","key":"6251_CR25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2022.05.006","volume":"77","author":"Z Ma","year":"2022","unstructured":"Ma Z, de Man RA, Kamar N, Pan Q (2022) Chronic hepatitis E: advancing research and patient care. J Hepatol 77(4):1109\u20131123. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.006","journal-title":"J Hepatol"},{"issue":"1","key":"6251_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14744\/hf.2020.2020.0030","volume":"2","author":"F \u00c7elik","year":"2021","unstructured":"\u00c7elik F, \u015eenkaya A, Unal NG, Aslanov S, Uysal A, Zeytino\u01e7lu A, Turan I, Zeytunlu M, \u00d6z\u00fctemi\u030az O, Akarca US, Karasu Z, G\u00fcn\u015far F (2021) Hepatitis E virus IgG seroprevalence in liver transplant patients: a retrospective single-center experience. Hepatol Forum 2(1):7\u201311. https:\/\/doi.org\/10.14744\/hf.2020.2020.0030","journal-title":"Hepatol Forum"},{"key":"6251_CR27","doi-asserted-by":"publisher","unstructured":"Haller IE, Reinwald M, Kah J, Eggert FAM, Schwarzlose-Schwarck S, Jahnke K, L\u00fcth S, Dammermann W (2025) Low serological agreement of hepatitis E in immunocompromised cancer patients: a comparative study of three anti-HEV assays. Antibodies 14(2). https:\/\/doi.org\/10.3390\/antib14020027","DOI":"10.3390\/antib14020027"},{"issue":"2","key":"6251_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/jvh.13424","volume":"28","author":"M Ankcorn","year":"2021","unstructured":"Ankcorn M, Said B, Morgan D, Elsharkawy AM, Maggs J, Ryder S, Valliani T, Gordon F, Abeysekera K, Suri D, McPherson S, Galliford J, Smith B, Pelosi E, Bansal S, Bethune C, Sheridan D, Vine L, Tedder RS, Ijaz S, Riley U, Zuckerman M, Dalton HR, Healy B, Donati M, Bicknell K, Evans C, Poller B, Smit E, van Halsema C, Williams E, Raza M, McGann H, Irving W, Douthwaite S, Ch\u2019Ng CL, McCaughey C, Irish D (2021) Persistent hepatitis E virus infection across England and Wales 2009\u20132017: Demography, virology and outcomes. J Viral Hepatitis 28(2):420\u2013430. https:\/\/doi.org\/10.1111\/jvh.13424","journal-title":"J Viral Hepatitis"},{"key":"6251_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijid.2019.11.014","volume":"91","author":"LH Harritsh\u00f8j","year":"2020","unstructured":"Harritsh\u00f8j LH, Hother CE, Sengel\u00f8v H, Daugaard G, Sorensen SS, Jacobsen S, Perch M, Holm DK, Saekmose SG, Aagaard B, Erikstrup C, Hogema BM, Lundgren JD, Ullum H (2020) Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients. Int J Infect Dis 91:188\u2013195. https:\/\/doi.org\/10.1016\/j.ijid.2019.11.014","journal-title":"Int J Infect Dis"},{"key":"6251_CR30","doi-asserted-by":"publisher","unstructured":"Hoffmann P, Behnisch R, Gsenger J, Schnitzler P, Gauss A (2020) Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases. PLoS ONE 15(10). https:\/\/doi.org\/10.1371\/journal.pone.0239825","DOI":"10.1371\/journal.pone.0239825"},{"issue":"11","key":"6251_CR31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/jvh.13129","volume":"26","author":"A Bergl\u00f8v","year":"2019","unstructured":"Bergl\u00f8v A, Hallager S, Weis N (2019) Hepatitis E during pregnancy: Maternal and foetal case-fatality rates and adverse outcomes\u2014A systematic review. J Viral Hepatitis 26(11):1240\u20131248. https:\/\/doi.org\/10.1111\/jvh.13129","journal-title":"J Viral Hepatitis"},{"issue":"11","key":"6251_CR32","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/jvh.13994","volume":"31","author":"P Wasuwanich","year":"2024","unstructured":"Wasuwanich P, Wen T, Egerman R, Karnsakul W (2024) Epidemiology and outcomes of hepatitis E virus-associated hospitalisations in the United States with a focus on pregnancy: a nationwide population study, 1998\u20132020. J Viral Hepatitis 31(11):710\u2013719. https:\/\/doi.org\/10.1111\/jvh.13994","journal-title":"J Viral Hepatitis"},{"key":"6251_CR33","doi-asserted-by":"publisher","unstructured":"Kogias D, Gavriilidis E, Antoniadou C, Skeva A, Kafalis N, Tsilingiris D, Kanellis G, Panopoulou M, Mitroulis I, Ritis K, Skendros P, Kouklakis G (2025) Hepatitis E infection in immunocompromised patients previously treated With Rituximab. J Viral Hepatitis 32(3). https:\/\/doi.org\/10.1111\/jvh.70005","DOI":"10.1111\/jvh.70005"},{"key":"6251_CR34","doi-asserted-by":"publisher","unstructured":"P\u00e9rez FJC, Mart\u00edn Garrido EP, Antona-Herranz M, Bailador-Andr\u00e9s C, Conde-Gacho P, Diego-Cobos CD, Rodr\u00edguez-G\u00f3mez SJ (2024) An acute infection due to hepatitis E in the context of a patient with rituximab and methotrexate therapy. Eur J Case Rep Intern Med 11(4). https:\/\/doi.org\/10.12890\/2024_004378","DOI":"10.12890\/2024_004378"},{"key":"6251_CR35","doi-asserted-by":"publisher","unstructured":"Schulz M, Biedermann P, Bock CT, Hofmann J, Choi M, Tacke F, Hanitsch LG, Mueller T (2020) Rituximab-containing treatment regimens may imply a long-term risk for difficult-to-treat chronic hepatitis E. Int J Environ Res Public Health 17(1). https:\/\/doi.org\/10.3390\/ijerph17010341","DOI":"10.3390\/ijerph17010341"},{"key":"6251_CR36","doi-asserted-by":"publisher","unstructured":"Kinast V, Andreica I, Ahrenstorf G, G\u00f6mer A, Elsner C, Schlienkamp S, Schrader JA, Kl\u00f6hn M, Ulrich RG, Broering R, Vondran FWR, Todt D, Behrendt P, Dittmer U, Hamprecht A, Witte T, Baraliakos X, Steinmann E (2023) Janus kinase-inhibition modulates hepatitis E virus infection. Antiviral Research 217https:\/\/doi.org\/10.1016\/j.antiviral.2023.105690.","DOI":"10.1016\/j.antiviral.2023.105690"},{"key":"6251_CR37","doi-asserted-by":"publisher","unstructured":"Kupke P, Werner JM (2021) Hepatitis e virus infection\u2014immune responses to an underestimated global threat. Cells 10(9). https:\/\/doi.org\/10.3390\/cells10092281","DOI":"10.3390\/cells10092281"},{"issue":"2","key":"6251_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jbspin.2016.09.017","volume":"84","author":"P Behrendt","year":"2017","unstructured":"Behrendt P, L\u00fcth S, Dammermann W, Drave S, Brown RJP, Todt D, Schnoor U, Steinmann E, Wedemeyer H, Pischke S, Iking-Konert C (2017) Exacerbation of hepatitis E virus infection during anti-TNF\u03b1 treatment. Jt Bone Spine 84(2):217\u2013219. https:\/\/doi.org\/10.1016\/j.jbspin.2016.09.017","journal-title":"Joint Bone Spine"},{"issue":"10","key":"6251_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.gastrohep.2023.01.010","volume":"46","author":"M Riveiro-Barciela","year":"2023","unstructured":"Riveiro-Barciela M, Roade L, Mart\u00ednez-Campreci\u00f3s J, Vidal-Gonz\u00e1lez J, Rodr\u00edguez-D\u00edez B, Perell\u00f3 M, Ort\u00ed G, Robles-Alonso V, Berastegui C, Navarro J, Mart\u00ednez-Valle F, Bilbao I, Castells L, Ventura-Cots M, Llaneras J, Rando-Segura A, Forns X, Lens S, Prieto M, Garc\u00eda-Eliz M, Imaz A, Rodr\u00edguez-Fr\u00edas F, But\u00ed M, Esteban R (2023) mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels). Gastroenterol Hepatol 46(10):764\u2013773. https:\/\/doi.org\/10.1016\/j.gastrohep.2023.01.010","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"6251_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jiy504","volume":"219","author":"M Ankcorn","year":"2019","unstructured":"Ankcorn M, Moreira F, Ijaz S, Symes A, Buckland MS, Workman S, Warburton F, Tedder RS, Lowe DM (2019) Absence of persistent hepatitis E virus infection in antibody-deficient patients is associated with transfer of antigen-neutralizing antibodies from immunoglobulin products. J Infect Dis 219(2):245\u2013253. https:\/\/doi.org\/10.1093\/infdis\/jiy504","journal-title":"J Infect Dis"},{"issue":"5","key":"6251_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/QCO.0000000000000590","volume":"32","author":"P Colson","year":"2019","unstructured":"Colson P, Decoster C (2019) Recent data on hepatitis E. Curr Opin Infect Dis 32(5):475\u2013481. https:\/\/doi.org\/10.1097\/QCO.0000000000000590","journal-title":"Curr Opin Infect Dis"},{"key":"6251_CR42","doi-asserted-by":"publisher","unstructured":"Pavlova A, Kocikova B, Dolinsk\u00e1 MU, Jackov\u00e1 A (2025) Hepatitis E virus in the role of an emerging food-borne pathogen. Microorganisms 13(4). https:\/\/doi.org\/10.3390\/microorganisms13040885","DOI":"10.3390\/microorganisms13040885"},{"key":"6251_CR43","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.onehlt.2025.101302","volume":"22","author":"H Wang","year":"2026","unstructured":"Wang H, Patzi-Churqui M, Andius LD, Nystr\u00f6m K, Lagging M (2026) Genetic insights into hepatitis E virus through environmental surveillance in Europe. One Health 22:101302. https:\/\/doi.org\/10.1016\/j.onehlt.2025.101302","journal-title":"One Health"},{"issue":"4","key":"6251_CR44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jhep.2022.05.019","volume":"77","author":"J Kemming","year":"2022","unstructured":"Kemming J, Gundlach S, Panning M, Huzly D, Huang J, L\u00fctgehetmann M, Pischke S, Schulze-Zur-Wiesch J, Emmerich F, Llewellyn-Lacey S, Price DA, Tanriver Y, Warnatz K, B\u00f6ettler T, Thimme R, Hofmann M, Fischer N, Neumann-Haefelin C (2022) Mechanisms of CD8\u2009+\u2009T-cell failure in chronic hepatitis E virus infection. J Hepatol 77(4):978\u2013990. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.019","journal-title":"J Hepatol"},{"key":"6251_CR45","doi-asserted-by":"publisher","unstructured":"Di Bartolomeo S, Carubbi F, Cipriani P (2020) Hepatitis e Virus and rheumatic diseases: What do rheumatologists need to know? BMC Rheumatol 4(1). https:\/\/doi.org\/10.1186\/s41927-020-00149-0","DOI":"10.1186\/s41927-020-00149-0"},{"key":"6251_CR46","doi-asserted-by":"publisher","unstructured":"Hanitsch LG, Muche M, Radbruch H, Hofmann J, Corman VM (2024) Fatal disseminated hepatitis E in an adult patient with IKBKB GOF mutation. J Clin Immunol 44(5). https:\/\/doi.org\/10.1007\/s10875-024-01721-w","DOI":"10.1007\/s10875-024-01721-w"},{"issue":"12","key":"6251_CR47","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1111\/liv.13894","volume":"38","author":"O Marion","year":"2018","unstructured":"Marion O, Abravanel F, del Bello A, Esposito L, Lhomme S, Puissant-Lubrano B, Alric L, Faguer S, Izopet J, Kamar N (2018) Hepatitis E virus\u2013associated cryoglobulinemia in solid-organ\u2013transplant recipients. Liver Int 38(12):2178\u20132189. https:\/\/doi.org\/10.1111\/liv.13894","journal-title":"Liver Int"},{"issue":"1","key":"6251_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/1744-9987.13507","volume":"25","author":"A Tavakoli","year":"2021","unstructured":"Tavakoli A, Alavian SM, Moghoofei M, Mostafaei S, Abbasi S, Farahmand M (2021) Seroepidemiology of hepatitis E virus infection in patients undergoing maintenance hemodialysis: systematic review and meta-analysis. Therapeutic Apheresis Dialysis 25(1):4\u201315. https:\/\/doi.org\/10.1111\/1744-9987.13507","journal-title":"Therapeutic Apheresis Dialysis"},{"issue":"1","key":"6251_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3748\/wjg.v28.i1.47","volume":"28","author":"CKM Cheung","year":"2022","unstructured":"Cheung CKM, Law MF, Wong SH, Law AWH (2022) Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol 28(1):47\u201375. https:\/\/doi.org\/10.3748\/wjg.v28.i1.47","journal-title":"World J Gastroenterol"},{"key":"6251_CR50","doi-asserted-by":"publisher","unstructured":"Pischke S, P\u00e9ron JM, von Wulffen M, von Felden J, H\u00f6ner zu Siederdissen CHZ, Fournier S, L\u00fctgehetmann M, Iking-Konert C, Bettinger D, P\u00e1r G, Thimme R, Cantagrel A, Lohse AW, Wedemeyer H, de Man RA, Mallet V (2019) Chronic hepatitis e in rheumatology and internal medicine patients: a retrospective multicenter european cohort study. Viruses 11(2). https:\/\/doi.org\/10.3390\/v11020186","DOI":"10.3390\/v11020186"},{"key":"6251_CR51","doi-asserted-by":"publisher","unstructured":"Bauer H, Luxembourger C, Gottenberg JE, Fournier S, Abravanel F, Cantagrel A, Chatelus E, Claudepierre P, Hudry C, Izopet J, Fabre S, Lef\u00e8vre G, Marguerie L, Martin A, Messer L, Molt\u00f5 A, Pallot-Prad\u00e8s B, Pers YM, Roque-Afonso AM, Roux C, Sordet C, Soubrier M, Veissier C, Wendling D, P\u00e9ron JM, Sibilia J (2015) Outcome of hepatitis e virus infection in patients with inflammatory arthritides treated with immunosuppressants. Med (United States) 94(14). https:\/\/doi.org\/10.1097\/MD.0000000000000675","DOI":"10.1097\/MD.0000000000000675"},{"issue":"2","key":"6251_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/24725625.2017.1288344","volume":"1","author":"D Kobayashi","year":"2017","unstructured":"Kobayashi D, Ito S, Takai C, Abe A, Ishikawa H, Murasawa A, Narita I, Nagoshi S, Nakazono K (2017) Type-E hepatitis in rheumatoid arthritis patients. Mod Rheumatol Case Rep 1(2):30\u201334. https:\/\/doi.org\/10.1080\/24725625.2017.1288344","journal-title":"Mod Rheumatol Case Rep"},{"issue":"10","key":"6251_CR53","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00296-022-05143-y","volume":"42","author":"T Zeki\u0107","year":"2022","unstructured":"Zeki\u0107 T, Beni\u0107 MS, Radi\u0107 M (2022) Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease. Rheumatol Int 42(10):1665\u20131679. https:\/\/doi.org\/10.1007\/s00296-022-05143-y","journal-title":"Rheumatol Int"},{"issue":"1","key":"6251_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12026-021-09178-4","volume":"69","author":"H Gui","year":"2021","unstructured":"Gui H, Wang W, Li Q, Li Z, Lu J, Xie Q (2021) Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infection. Immunol Res 69(1):81\u201389. https:\/\/doi.org\/10.1007\/s12026-021-09178-4","journal-title":"Immunol Res"},{"issue":"3","key":"6251_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000441387","volume":"9","author":"T Kanda","year":"2015","unstructured":"Kanda T, Yasui S, Nakamura M, Arai M, Sasaki-Tanaka R, Haga Y, Wu S, Nakamoto S, Okamoto H, Yokosuka O (2015) Recent trend of Hepatitis E virus infection in Chiba Area, Japan: 3 of 5 cases with rheumatoid arthritis. Case Rep Gastroenterol 9(3):317\u2013326. https:\/\/doi.org\/10.1159\/000441387","journal-title":"Case Rep Gastroenterol"},{"issue":"1","key":"6251_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00296-024-05766-3","volume":"45","author":"A Karkabayeva","year":"2024","unstructured":"Karkabayeva A, Mirakhmedova K, Khusinova S, Mamasaidov A, Baimukhamedov C (2024) COVID-19 is a trigger of autoimmune rheumatic diseases: a hypothesis tested over time. Rheumatol Int 45(1):11. https:\/\/doi.org\/10.1007\/s00296-024-05766-3","journal-title":"Rheumatol Int"},{"issue":"2","key":"6251_CR57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/24725625.2021.1905204","volume":"5","author":"B Dalton","year":"2021","unstructured":"Dalton B, Cunnane G, Conway R (2021) Acute hepatitis E in an immunocompromised patient with seropositive rheumatoid arthritis on rituximab and long-term methotrexate. Mod Rheumatol Case Rep 5(2):226\u2013228. https:\/\/doi.org\/10.1080\/24725625.2021.1905204","journal-title":"Mod Rheumatol Case Rep"},{"key":"6251_CR58","doi-asserted-by":"publisher","unstructured":"Kounis I, Renou C, Nahon S, Heluwaert F, MacAigne G, Amil M, Talom S, Lambar\u00e9 B, Charpignon C, Paupard T, Stetiu M, Ripault MP, Yamaga A, Ehrhard F, Audemar F, Ortiz Correro MC, Zanditenas D, Skinazi F, Agostini H, Coilly A, Roque-Afonso AM (2023) Hepatitis E virus infection in patients with chronic inflammatory bowel disease treated with immunosuppressive therapy. Pathogens 12(2). https:\/\/doi.org\/10.3390\/pathogens12020332","DOI":"10.3390\/pathogens12020332"},{"key":"6251_CR59","doi-asserted-by":"publisher","unstructured":"Horvatits T, Schulze-Zur-Wiesch J, L\u00fctgehetmann M, Lohse AW, Pischke S (2019) The clinical perspective on hepatitis E. Viruses 11(7). https:\/\/doi.org\/10.3390\/v11070617","DOI":"10.3390\/v11070617"},{"issue":"2","key":"6251_CR60","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.dld.2024.06.020","volume":"57","author":"P Kupke","year":"2025","unstructured":"Kupke P, Kupke M, Borgmann S, Kandulski A, Hitzenbichler F, Menzel J, Geissler EK, Schlitt HJ, Wenzel JJ, Werner JM (2025) Hepatitis E virus infection in immunosuppressed patients and its clinical manifestations. Dig Liver Disease 57(2):378\u2013384. https:\/\/doi.org\/10.1016\/j.dld.2024.06.020","journal-title":"Dig Liver Disease"},{"issue":"3","key":"6251_CR61","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jinf.2021.07.021","volume":"83","author":"J Wu","year":"2021","unstructured":"Wu J, Xiang Z, Zhu C, Yao Y, Bortolanza M, Cao H, Li L (2021) Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms. J Infect 83(3):298\u2013305. https:\/\/doi.org\/10.1016\/j.jinf.2021.07.021","journal-title":"J Infect"},{"issue":"1","key":"6251_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.livres.2024.01.001","volume":"8","author":"Q Luo","year":"2024","unstructured":"Luo Q, Chen J, Zhang Y, Xu W, Liu Y, Xie C, Peng L (2024) Viral hepatitis E: clinical manifestations, treatment, and prevention. Liver Res 8(1):11\u201321. https:\/\/doi.org\/10.1016\/j.livres.2024.01.001","journal-title":"Liver Res"},{"issue":"9","key":"6251_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens9090755","volume":"9","author":"T Horvatits","year":"2020","unstructured":"Horvatits T, Schulze-Zur-Wiesch JSZ, Polywka S, Buescher G, L\u00fctgehetmann M, Hussey E, Horvatits K, Peine S, Haag F, Addo MM, Lohse AW, Weiler-Normann C, Pischke S (2020) Significance of anti-nuclear antibodies and cryoglobulins in patients with acute and chronic HEV infection. Pathogens 9(9):1\u201312. https:\/\/doi.org\/10.3390\/pathogens9090755","journal-title":"Pathogens"},{"key":"6251_CR64","doi-asserted-by":"publisher","unstructured":"Lhomme S, Abravanel F, Cintas P, Izopet J (2021) Hepatitis e virus infection: neurological manifestations and pathophysiology. Pathogens 10(12). https:\/\/doi.org\/10.3390\/pathogens10121582","DOI":"10.3390\/pathogens10121582"},{"issue":"1","key":"6251_CR65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3350\/cmh.2019.0082","volume":"26","author":"FS Fousekis","year":"2020","unstructured":"Fousekis FS, Mitselos IV, Christodoulou DK (2020) Extrahepatic manifestations of hepatitis E virus: an overview. Clin Mol Hepatol 26(1):16\u201323. https:\/\/doi.org\/10.3350\/cmh.2019.0082","journal-title":"Clin Mol Hepatol"},{"key":"6251_CR66","doi-asserted-by":"publisher","unstructured":"Guo Z, Tian Y, Cheng M, Yin W, Sun Y, Ou Y, Peng X, Liu T, She R, Hu Y, Tian J (2026) Hepatitis E virus-associated neurological injury and neurotropic cellular mechanisms. Front Cell Infect Microbiol 16. https:\/\/doi.org\/10.3389\/fcimb.2026.1810452","DOI":"10.3389\/fcimb.2026.1810452"},{"key":"6251_CR67","doi-asserted-by":"publisher","unstructured":"Kamar N, del Bello A, Abravanel F, Pan Q, Izopet J (2022) Unmet needs for the treatment of chronic hepatitis E virus infection in immunocompromised patients. Viruses 14(10). https:\/\/doi.org\/10.3390\/v14102116","DOI":"10.3390\/v14102116"},{"issue":"4","key":"6251_CR68","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/liv.13037","volume":"36","author":"N Kamar","year":"2016","unstructured":"Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR (2016) Extrahepatic manifestations of hepatitis E virus. Liver Int 36(4):467\u2013472. https:\/\/doi.org\/10.1111\/liv.13037","journal-title":"Liver Int"},{"issue":"7","key":"6251_CR69","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cmi.2020.03.039","volume":"26","author":"GW Webb","year":"2020","unstructured":"Webb GW, Dalton HR (2020) Hepatitis E: an expanding epidemic with a range of complications. Clin Microbiol Infect 26(7):828\u2013832. https:\/\/doi.org\/10.1016\/j.cmi.2020.03.039","journal-title":"Clin Microbiol Infect"},{"key":"6251_CR70","doi-asserted-by":"publisher","unstructured":"Jacob S, Kapadia R, Soule T, Luo H, Schellenberg KL, Douville RN, Pfeffer G (2022) Neuromuscular complications of SARS-CoV-2 and other viral infections. Front Neurol 13. https:\/\/doi.org\/10.3389\/fneur.2022.914411","DOI":"10.3389\/fneur.2022.914411"},{"issue":"2","key":"6251_CR71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clineuro.2008.09.005","volume":"111","author":"F Fong","year":"2009","unstructured":"Fong F, Illahi M (2009) Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 111(2):193\u2013195. https:\/\/doi.org\/10.1016\/j.clineuro.2008.09.005","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"6251_CR72","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.dld.2013.05.006","volume":"45","author":"AM Peri","year":"2013","unstructured":"Peri AM, Milazzo L, Meroni L, Antinori S (2013) Radiculoneuropathy associated with acute hepatitis E. Dig Liver Disease 45(11):963\u2013964. https:\/\/doi.org\/10.1016\/j.dld.2013.05.006","journal-title":"Dig Liver Disease"},{"issue":"3","key":"6251_CR73","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/gastro\/gox021","volume":"5","author":"F Bazerbachi","year":"2017","unstructured":"Bazerbachi F, Leise MD, Watt KD, Murad MH, Prokop LJ, Haffar S (2017) Systematic review of mixed cryoglobulinemia associated with hepatitis E virus infection: Association or causation? Gastroenterol Rep 5(3):178\u2013184. https:\/\/doi.org\/10.1093\/gastro\/gox021","journal-title":"Gastroenterol Rep"},{"key":"6251_CR74","doi-asserted-by":"publisher","unstructured":"Ma\u015bli\u0144ska M, Kostyra-Grabczak K (2022) The role of virus infections in Sj\u00f6gren\u2019s syndrome. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.823659","DOI":"10.3389\/fimmu.2022.823659"},{"issue":"4","key":"6251_CR75","doi-asserted-by":"publisher","first-page":"91","DOI":"10.59556\/japi.72.0499","volume":"72","author":"N Desai","year":"2024","unstructured":"Desai N, Vetal D, Kulkarni A, Karnik N, Trivedi T (2024) Hemophagocytic lymphohistiocytosis: a rare complication of acute hepatitis E infection. J Association Physicians India 72(4):91\u201393. https:\/\/doi.org\/10.59556\/japi.72.0499","journal-title":"J Association Physicians India"},{"key":"6251_CR76","doi-asserted-by":"publisher","unstructured":"Masset C, Le Turnier P, Bressollette-Bodin C, Renaudin K, Raffi F, Dantal J (2022) Virus-associated nephropathies: a narrative review. Int J Mol Sci 23(19). https:\/\/doi.org\/10.3390\/ijms231912014","DOI":"10.3390\/ijms231912014"},{"issue":"2","key":"6251_CR77","doi-asserted-by":"publisher","first-page":"100259","DOI":"10.1016\/j.imj.2026.100259","volume":"5","author":"J Shen","year":"2026","unstructured":"Shen J, Zhang S (2026) Hepatitis E virus and renal injury: a review of pathogenesis, pathology, and clinical management. Infect Med 5(2):100259. https:\/\/doi.org\/10.1016\/j.imj.2026.100259","journal-title":"Infect Med"},{"issue":"11","key":"6251_CR78","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s10067-007-0595-0","volume":"26","author":"J Serratrice","year":"2007","unstructured":"Serratrice J, Disdier P, Colson P, En\u00e9 N, de Roux CS, Weiller PJ (2007) Acute polyarthritis revealing hepatitis E. Clin Rheumatol 26(11):1973\u20131975. https:\/\/doi.org\/10.1007\/s10067-007-0595-0","journal-title":"Clin Rheumatol"},{"issue":"8","key":"6251_CR79","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/ccr3.2167","volume":"7","author":"JF Viallard","year":"2019","unstructured":"Viallard JF, Vergier B, Lazaro E, Greib C, Pellegrin JL (2019) Cutaneous necrotizing small-vessel vasculitis induced by acute hepatitis E. Clin Case Rep 7(8):1539\u20131541. https:\/\/doi.org\/10.1002\/ccr3.2167","journal-title":"Clin Case Rep"},{"key":"6251_CR80","doi-asserted-by":"publisher","unstructured":"Takakusagi S, Kakizaki S, Takagi H (2023) The diagnosis, pathophysiology, and treatment of chronic hepatitis E virus infection\u2014A condition affecting immunocompromised patients. Microorganisms 11(5). https:\/\/doi.org\/10.3390\/microorganisms11051303","DOI":"10.3390\/microorganisms11051303"},{"issue":"6","key":"6251_CR81","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","volume":"68","author":"HR Dalton","year":"2018","unstructured":"Dalton HR, Kamar N, Baylis SA, Moradpour D, Wedemeyer H, Negro F (2018) EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol 68(6):1256\u20131271. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.005","journal-title":"J Hepatol"},{"key":"6251_CR82","doi-asserted-by":"publisher","unstructured":"Zeisbrich M, Wendel S, Finzel S, Voll RE, Venhoff N (2022) Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis. Orphanet J Rare Dis 17(1). https:\/\/doi.org\/10.1186\/s13023-022-02586-1","DOI":"10.1186\/s13023-022-02586-1"},{"issue":"1","key":"6251_CR83","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.advms.2026.02.003","volume":"71","author":"A Parfieniuk-Kowerda","year":"2026","unstructured":"Parfieniuk-Kowerda A, Jaroszewicz J, Grabarczyk P, Zarebska-Michaluk D, Sikorska K, Piekarska A, Berkan-Kawinska A, Kozielewicz D, Pawlowska M, Pazgan-Simon M, Sobala-Szczygiel B, Zielinski P, Rydzewski A, Serwacka A, Tomasiewicz K, Budziszewska BK, Flisiak R (2026) Clinical characteristics of hospitalized patients with hepatitis E virus infection in Poland: a multi-centre retrospective study. Adv Med Sci 71(1):75\u201382. https:\/\/doi.org\/10.1016\/j.advms.2026.02.003","journal-title":"Adv Med Sci"},{"key":"6251_CR84","doi-asserted-by":"publisher","unstructured":"Rafiei A, Ajami A, Mirabi AM, Saffar MJ, Amjadi O, Haghshenas MR, Abedian F, Khaje-Enayati P (2016) Serum levels of soluble CD26, a novel prognostic marker for hepatitis E infection. Jundishapur J Microbiol 9(2). https:\/\/doi.org\/10.5812\/jjm.31110","DOI":"10.5812\/jjm.31110"},{"key":"6251_CR85","doi-asserted-by":"publisher","unstructured":"Gr\u00fcmme L, Schulze-Koops H (2023) Management of a patient with common variable immunodeficiency and hepatopathy. Allergy Asthma Clin Immunol 19(1). https:\/\/doi.org\/10.1186\/s13223-023-00799-y","DOI":"10.1186\/s13223-023-00799-y"},{"key":"6251_CR86","doi-asserted-by":"publisher","unstructured":"Gabrielli F, Alberti F, Russo C, Cursaro C, Seferi H, Margotti M, Andreone P (2023) Treatment Options for Hepatitis A and E: A Non-Systematic Review. Viruses 15(5). https:\/\/doi.org\/10.3390\/v15051080","DOI":"10.3390\/v15051080"},{"issue":"3","key":"6251_CR87","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/jvh.13456","volume":"28","author":"M Gorris","year":"2021","unstructured":"Gorris M, van der Lecq BM, van Erpecum KJ, de Bruijne J (2021) Treatment for chronic hepatitis E virus infection: a systematic review and meta-analysis. J Viral Hepatitis 28(3):454\u2013463. https:\/\/doi.org\/10.1111\/jvh.13456","journal-title":"J Viral Hepatitis"},{"issue":"12","key":"6251_CR88","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/jvh.12403","volume":"22","author":"AM van Peters","year":"2015","unstructured":"van Peters AM, Gevers TJG, Drenth JPH (2015) Antiviral therapy in chronic hepatitis E: a systematic review. J Viral Hepatitis 22(12):965\u2013973. https:\/\/doi.org\/10.1111\/jvh.12403","journal-title":"J Viral Hepatitis"},{"issue":"7\u20138","key":"6251_CR89","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000531538","volume":"46","author":"V Ingwersen","year":"2023","unstructured":"Ingwersen V, Hofmann J, Muche M, Le Coutre P, Schneider T, Leng C, Burmeister T, Maschmeyer G, Keller U, Schwartz S (2023) Variable outcomes of hepatitis E infections in patients with hemato-oncologic diseases. Oncol Res Treat 46(7\u20138):296\u2013302. https:\/\/doi.org\/10.1159\/000531538","journal-title":"Oncol Res Treat"},{"issue":"10","key":"6251_CR90","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-020-04639-9","volume":"40","author":"S Shah","year":"2020","unstructured":"Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS (2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 40(10):1539\u20131554. https:\/\/doi.org\/10.1007\/s00296-020-04639-9","journal-title":"Rheumatol Int"},{"issue":"4","key":"6251_CR91","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jceh.2022.02.003","volume":"12","author":"T Lampejo","year":"2022","unstructured":"Lampejo T (2022) Sofosbuvir in the Treatment of Hepatitis E virus infection: a review of in vitro and in vivo evidence. J Clin Experimental Hepatol 12(4):1225\u20131237. https:\/\/doi.org\/10.1016\/j.jceh.2022.02.003","journal-title":"J Clin Experimental Hepatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06251-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06251-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:37:48Z","timestamp":1786937868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06251-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":91,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["6251"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06251-9","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Large Language Models were not used at any stage of the study.","order":1,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"220"}}